Rituximab is an anti-CD20 monoclonal antibody that suppresses inflammation effectively in autoimmune diseases. It was initially approved by the FDA for the treatment of B-cell lymphomas and later ...

Some of the newest treatment options available and in testing include: Biosimilars: These drugs are very close in structure and function to biological drugs. Biosimilars offer a more affordable option ...

By using three broad types of measurements—working capital, asset performance, and capital structure—you may evaluate the strength of a company's balance sheet and, thus, its investment quality.